Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases

摘要

Combination of R,R-glycopyrrolate, formoterol and a glucocorticoid selected from budesonide and mometasone or their physiologically acceptable salts is disclosed, wherein said combination is suitable for the treatment of inflammatory diseases selected form the group comprising respiratory diseases selected from asthma or COPD, rheumatism or auto-immune diseases selected from rheumatoid arthritis, glomerulonephritis, multiple sclerosis, Crohn's disease, ulcerative colitis, systemic lupus erythematosus or psoriasis.